Establishing Potent NK Cell Therapies Through Process Improvements
Time: 1:45 pm
day: Day Two Track C - PM
Details:
- Activation, programming and manufacturing of NK cells as stable and potent cell therapy products
- Approaches to enhance durability and formulate cytotoxic NK products for adoptive transfer
- Generation of off-the-shelf NK cell therapies by reducing immunogenicity and through sources including iPSCs
